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Figure 1. MAHDR and MALDR mice displayed conditioned place aversion to quinpirole
at dose 0.1 and 0.5 mg/kg. Shown are mean ± SEM sec/min on the grid floor during the 30-min CPP
tests with MAHDR (A-C) and MALDR (D-F) mice. Animals were conditioned with quinpirole with a dose of
0.1 or 0.5 mg/kg on the grid/black (G+) or on the mesh/white (G-) side of the box. ***p<.001 for the
difference between G- and G+ mice in the same dose group.
Figure 3. Locomotor activity levels during conditioning and CPP tests in both MAHDR
and MALDR were suppressed by quinpirole. Shown are means ± SEM # for movements in a 30
min CPP test (A-B) or in 15 min conditioning trials received quinpirole (C-D). In the pre-test and drug-free
test (A-B), mice received saline; in the drug-present test (A-B) they received quinpirole. Conditioning
sessions (C-D) were alternated between vehicle and quinpirole in a counterbalanced order. ***p<.001
significant mean difference between the pre-test and other preference test sessions (A-B); +++p<.001
significant mean difference between drug-free and drug-present preference tests (B); ***p<.001 significant
mean difference between treatments (C-D); +++p<.001 significant mean difference between dose groups
(C-D); #p<.05, p<.01, and ###p<.001 significant difference from the first day within a treatment group (C-
D).
Figure 1. Unbiased condition place preference procedure. A two-compartment CPP
apparatus was split by a guillotine door into a left chamber having white wall with a mesh
floor and a right chamber having black walls with a grid floor. IR photobeams along the walls
detected movement. Mice were given access to both chambers during pre- and post-CPP
tests and were restricted to one side during conditioning.
Adult mice (age=111-137 days) from MAHDR and MALDR lines (n=12 per sex per line) were
sent from Oregon Health & Science University in Portland, OR to Grand Valley State
University (GVSU), Allendale MI. Mice were acclimated for three weeks at the GVSU
vivarium before the start of experiment. Following this, mice were subjected to an 18-day
conditioned place preference (CPP) procedure (see diagram below) where quinpirole was
administered intraperitoneally (IP) at doses of 0.05, 0.1, and 0.5 mg/kg (n=6 per line per sex
per dose). For the next two days, thermic responses to vehicle and quinpirole were measured
in a random order.
• Quinpirole induced significant conditioned place aversion in both lines at modest doses,
suggestive that the Drd2 is involved in the aversive properties of MA.
• In mice, administration of modest doses of quinpirole induced significant locomotor
suppression, indicative of activation of D2 autoreceptors.
• While locomotor suppression was comparable in the MADR lines, MALDR mice alone
demonstrated a compensatory locomotor increase on the drug-free test day. This
supports an interaction between the D2R and other genetic risk factors for MA use.
• Low dose of quinpirole induced a modest suppression of locomotor activity compared to
saline treatment, only in MALDR mice. In both lines, low dose of quinpirole induced a
locomotor sensitization, and a compensatory increase in locomotor activity during the
saline (non-drug) days.
• Methamphetamine (MA) is a highly addictive psychostimulant and its use represents a
major burden to public health. Despite this, its mechanism as a psychostimulant is not
fully understood and there are no approved medications to assist in treatment1.
• Risk for MA use is influenced by initial sensitivity to its rewarding and aversive properties2.
• To induce these effects, MA acts as an indirect agonist on dopamine motivational
pathways, which includes dopamine D2 receptors (DR2)2.
• In a genetic mouse model, mice selectively bred for low MA intake (MALDR) displayed
higher sensitivity for aversive properties of MA, whereas mice selectively bred for high MA
intake (MAHDR) displayed high sensitivity to the rewarding effects of MA3. Furthermore,
MA induces hypothermia in MALDR and hyperthermia in MAHDR mice4.
• Previous pilot studies in our lab have shown that quinpirole, a D2R agonist, can induce
hypothermia in MADR mice and their progenitor strains (DBA/2J and C57BL/6J).
• In this study we sought to clarify the role of the D2 receptor in MA motivational effects by testing
MADR mice for the rewarding or aversive effects of the D2R agonist, quinpirole, in a condition
place preference procedure. We predicted that treatment with quinpirole would induce different
levels of hypothermia and different motivational effects in mice with differing innate MA
sensitivities.
FUTURE DIRECTIONS 
Future experiments will be aimed at understanding the interaction between dopamine D2
receptor, and trace-associated amine receptor 1 (TAAR1). The TAAR1 is non-functional in
MAHDR mice, but functional in MALDR mice2. TAAR1 activation also induces CPA, and is
thought to share the same transduction pathways with dopamine D2 receptor2.
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OBJECTIVE 
The objective of this study was to explore the contribution of dopamine D2 receptor to
the rewarding and aversive effects of methamphetamine using a genetic mouse model
for MA intake.
Figure 4. MAHDR and MALDR mice displayed no conditioned place aversion to
low quinpirole dose 0.01 mg/kg. (A) Shown are mean ± SEM sec/min on the grid floor during the
30-min CPP tests with MAHDR and MALDR mice. Shown are mean ± SEM total beam breaks, indicating
locomotor activity during the 30-min CPP tests (B), and during 15-min conditioning trials (C). *p<.05,
***p<.001 mean difference between pre-test treatment and either drug-free and drug-present tests.
+++p<.001 mean difference between drug-free and drug-present test day. ###p<.001 mean difference by
treatment during conditioning trials in MALDR mice. ⍺⍺⍺p<.001 increase in locomotor activity during
conditioning trials.
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